Description
Basic introduction
Tirzepatide is a synthetic peptide investigated through both GIP and GLP-1 receptor pathways. Its structure includes a lipid modification, which is relevant to the pharmacological preparation described in the scientific literature.
The research spans receptor assays, animal models and clinical studies. These evidence levels should remain separate: a receptor response characterizes one aspect of a molecule, while a clinical study concerns a defined formulation, population and protocol.
Mechanism of action · Research context
GIP receptor response
Tirzepatide was characterized as a GIP receptor agonist. Receptor-specific assays help define this activity independently of its response at the GLP-1 receptor.
GLP-1 receptor response
GLP-1 receptor activity provides a second experimental pathway. Comparing signaling in matched assay systems is more informative than assuming equal activity at both receptors from the dual-agonist label alone.
Integrated metabolic effects
Whole-system responses involve more than receptor activation. The discovery program examined glucose-dependent insulin secretion and metabolic outcomes across several experimental settings.
Extended research considerations
Receptor assay controls
Identify the receptor expression system and readout. Differences in receptor abundance, assay timing or signal amplification can affect comparisons between GIP and GLP-1 responses.
Formulation and exposure
Lipid modification influences the tested preparation. Analytical identity, aggregation and compatibility with the assay medium are separate from the receptor-response result.
Clinical evidence context
Clinical trials evaluate specific pharmaceutical preparations. Their outcomes do not certify the identity, sterility or clinical suitability of a research product sold independently of those studies.
Material and packaging
Available kit specifications: 5 mg × 10 vials; 10 mg × 10 vials; 15 mg × 10 vials; 20 mg × 10 vials; 30 mg × 10 vials; 40 mg × 10 vials; 50 mg × 10 vials; 60 mg × 10 vials; 100 mg × 10 vials; 120 mg × 10 vials. Select an option above to view its current price and availability.
Storage and handling
Source-listed storage condition: Store at 20°C to 25°C (Do not freeze). Follow the handling instructions supplied with the actual batch and your laboratory's procedures.
Analytical documentation
Reference analytical documents are available with this listing. Check the material identity, batch number and test date against the batch supplied; contact us for current batch documentation.
Scientific references
These publications describe the studied molecules and experimental models. They do not certify the identity, quality or effects of a particular supplied batch.
- Discovery and experimental characterization of LY3298176
- Phase 2 tirzepatide clinical research
View report
View report
Wade P. –
Weekly subcutaneous injection makes my routine extremely easy. The acetic acid buffer keeps pH stable between 4.2–5.2 after mixing. The solution stays clear for days without degradation, and HPLC testing confirms purity is above 99%. I just keep vials at room temperature with no freezing needed.
Nora D. –
Potency stays consistent across all 10 vials, no big difference between doses. I only feel mild nausea on the first day after injection. The lyophilized powder dissolves completely without any solid residue left over.
Milo Hale –
My lab runs glucose tolerance and adipocyte metabolism research, TR10’s ≥99% HPLC purity eliminates impurity noise that skews blood sugar test readouts. The special room-temperature storage rule (20–25°C, no freezing) simplifies our inventory management. I once froze a test vial by accident; follow-up cell testing showed massive loss of dual GLP-1/GIP agonist activity. Reconstituted peptide liquid stays clear and stable for 5 days refrigerated, matching my weekly rodent injection timeline perfectly.
Hilda B. –
The 10mg vial size fits my weekly dosing plan perfectly, so I never waste leftover reconstituted peptide. The stable 4.2–5.2 pH range prevents protein denaturation and reduces unnecessary raw material waste in my lab experiments.
Yale R. –
No more mid-week hunger spikes. This formulation stabilizes blood sugar perfectly. The sealed vials avoid moisture damage during shipping, all glass bottles arrived intact. I can stick strictly to my calorie deficit without willpower struggles.